MedPath

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

Phase 3
Completed
Conditions
Contraception
Interventions
Registration Number
NCT00551616
Lead Sponsor
HRA Pharma
Brief Summary

The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
2221
Inclusion Criteria
  • women 16 or older in UK(except Northern Ireland) sites, 17 years or more in Northern Ireland (UK) and 18 years or more in Ireland and US
  • present within 120 hours of unprotected intercourse
  • regular menstrual cycles
  • No current use of hormonal contraception
  • Willing to not use hormonal methods of contraception until study completion
  • At least one complete menstrual cycle (2 menses) post miscarriage, delivery or abortion
  • For women who present more than 72 hours after intercourse, decline the insertion of an Intra Uterine Device for emergency contraception
  • Able to provide informed consent
  • Willing to abstain from further acts of unprotected intercourse until study completion
Exclusion Criteria
  • One or more acts of unprotected intercourse more than 120 hours
  • current or recent use of hormonal methods of contraception
  • currently pregnant or breastfeeding
  • tubal ligation or current use of IUD
  • Use of hormonal emergency contraception since last menstrual period
  • Current use of IUD
  • Tubal ligation
  • Partner with a vasectomy
  • Unsure about the date of the last menstrual period
  • Severe asthma insufficiently controlled by oral glucocorticoid
  • Hypersensitivity to the active substance levonorgestrel or any of the excipients of the drug products used in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CDB-2914CDB-2914-
LevonorgestrelLevonorgestrel-
Primary Outcome Measures
NameTimeMethod
Number of Participants With PregnancyWithin 72 hours of unprotected Intercourse

The rate of pregnancy in women who received emergency contraception within 72 h of unprotected sexual intercourse.

Secondary Outcome Measures
NameTimeMethod
Menstrual Bleeding Patternswithin the menstrual cycle of the unprotected Intercourse

Onset of next menses after emergency contraception compared to usual date.

Actual Pregnancy Rate Compared to Expected Pregnancy RateWithin 120 hours of unprotected Intercourse

Conditional probabilities of pregnancy from the time of unprotected sex intercourse to treatment were estimated for up to 120 hours using Spline Cubic Estimation (Stone \& Koo, 1985) Pregnancy rate expected in the absence of emergency contraception is based on Trussell J, Rodriguez G, Ellertson C. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception. 1998;57(6):363-9.

Trial Locations

Locations (24)

Planned Parenthood of the Rocky Mountains

🇺🇸

Littleton, Colorado, United States

Planned Parenthood of Texas Capitol Region

🇺🇸

Austin, Texas, United States

Planned Parenthood of Northeast Ohio Rocky River Health Center

🇺🇸

Rocky River, Ohio, United States

Planned Parenthood Association of Utah

🇺🇸

West Valley City, Utah, United States

NHS Grampian Sexual and Reproductive Health

🇬🇧

Aberdeen, United Kingdom

Brook Family Planning Clinic

🇬🇧

Belfast, United Kingdom

NHS Greater Glasgow & Clyde Family Planning Service

🇬🇧

Glasgow, United Kingdom

Nottingham Contraception & Sexual Health Service

🇬🇧

Nottingham, United Kingdom

London Sexual and Reproductive Health

🇬🇧

London, United Kingdom

Manchester Primary Care Trust

🇬🇧

Manchester, United Kingdom

Oxfordshire PCT Community Health

🇬🇧

Oxford, United Kingdom

Planned Parenthood Santa Monica

🇺🇸

Santa Monica, California, United States

Planned Parenthood Hollywood

🇺🇸

Los Angeles, California, United States

Planned Parenthood of Greater Miami

🇺🇸

West Palm Beach, Florida, United States

Planned Parenthood of Northeast Ohio Akron Health Center

🇺🇸

Akron, Ohio, United States

Planned Parenthood of Northeast Ohio East Cleveland Health Center

🇺🇸

Cleveland, Ohio, United States

Fannin Health Center

🇺🇸

Houston, Texas, United States

Planned Parenthood of Houston and Southeast Texas Research Department

🇺🇸

Houston, Texas, United States

Well Woman Centre

🇮🇪

Dublin, Ireland

Liverpool PCT Family Planning Services

🇬🇧

Liverpool, United Kingdom

Planned Parenthood of Northeast Ohio Bedford Health Center

🇺🇸

Bedford, Ohio, United States

Planned Parenthood of Northeast Ohio Old Brooklyn Health Center

🇺🇸

Cleveland, Ohio, United States

Planned Parenthood of Northeast Ohio Kent Health Center

🇺🇸

Kent, Ohio, United States

NHS Lothian Family Planning Service

🇬🇧

Edinburgh, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath